BioLife Solutions, Inc.
BLFS
$23.89
$0.602.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.24M | -49.66M | -77.09M | -54.31M | -57.80M |
| Total Depreciation and Amortization | 4.75M | 3.93M | 4.79M | 2.35M | 4.08M |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 13.00K |
| Total Other Non-Cash Items | 23.65M | 48.04M | 66.23M | 42.08M | 46.15M |
| Change in Net Operating Assets | 2.27M | 6.78M | 5.98M | 3.34M | 2.79M |
| Cash from Operations | 8.43M | 9.10M | -84.00K | -14.26M | -12.50M |
| Capital Expenditure | -1.53M | -3.11M | -3.96M | -4.78M | -9.08M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 59.83M | -8.27M | -4.08M | 10.18M | 17.62M |
| Cash from Investing | 58.30M | -11.38M | -8.04M | 14.69M | 17.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.90M | -2.29M | -1.00K | -242.00K | -369.00K |
| Issuance of Common Stock | 111.00K | 10.43M | 10.45M | 10.45M | 10.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -995.00K | -995.00K | -1.65M | -706.00K | -314.00K |
| Cash from Financing | -6.78M | 7.14M | 8.79M | 10.20M | 10.59M |
| Foreign Exchange rate Adjustments | 0.00 | 34.00K | -58.00K | -58.00K | 18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.95M | 4.90M | 614.00K | 10.59M | 15.97M |